IRIS - Res&Arch Institutional Research Information System - Research & Archive

Ingrosso, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.305
AS - Asia 2.397
EU - Europa 1.550
SA - Sud America 442
Continente sconosciuto - Info sul continente non disponibili 214
AF - Africa 56
OC - Oceania 5
Totale 7.969
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.195
SG - Singapore 1.313
IE - Irlanda 354
BR - Brasile 342
HK - Hong Kong 341
IT - Italia 334
CN - Cina 302
RU - Federazione Russa 292
FR - Francia 156
VN - Vietnam 133
DE - Germania 106
GB - Regno Unito 68
CA - Canada 53
BD - Bangladesh 49
KR - Corea 49
AR - Argentina 36
FI - Finlandia 35
UA - Ucraina 32
IN - India 30
PL - Polonia 29
NL - Olanda 25
MX - Messico 24
AT - Austria 23
JP - Giappone 22
TR - Turchia 22
SE - Svezia 19
CO - Colombia 18
IQ - Iraq 15
CH - Svizzera 14
ZA - Sudafrica 14
EC - Ecuador 13
ES - Italia 13
ID - Indonesia 13
PK - Pakistan 13
UZ - Uzbekistan 13
PH - Filippine 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
MA - Marocco 8
PE - Perù 8
CR - Costa Rica 7
LT - Lituania 7
MY - Malesia 7
BE - Belgio 6
IL - Israele 6
PY - Paraguay 6
TN - Tunisia 6
VE - Venezuela 6
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 5
JO - Giordania 5
KE - Kenya 5
BO - Bolivia 4
CL - Cile 4
DZ - Algeria 4
EE - Estonia 4
GR - Grecia 4
NP - Nepal 4
PS - Palestinian Territory 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
EG - Egitto 3
ET - Etiopia 3
IR - Iran 3
LB - Libano 3
NI - Nicaragua 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
Totale 7.744
Salva come PNG Salva come JPEG
Città #
Singapore 963
San Jose 390
Dublin 352
Hong Kong 340
Ashburn 281
Chandler 255
Boardman 160
Santa Clara 158
Council Bluffs 123
Altamura 120
San Mateo 119
Lauterbourg 86
Moscow 83
Princeton 79
Lawrence 73
Medford 73
Beijing 72
The Dalles 69
Los Angeles 60
New York 48
Seoul 48
Munich 42
Dallas 39
Ho Chi Minh City 38
São Paulo 38
Andover 33
Perugia 30
Wilmington 29
Houston 27
Hanoi 24
Frankfurt am Main 23
Milan 21
Atlanta 20
Buffalo 20
Piscataway 20
Tokyo 20
Warsaw 20
Ann Arbor 19
Des Moines 19
North Bergen 19
Brooklyn 18
Rome 18
Nuremberg 17
Saint Petersburg 17
Turku 17
Phoenix 16
Redmond 16
Toronto 16
Montreal 15
Norwalk 14
Brasília 13
Chicago 13
Orem 12
Amsterdam 11
Boston 11
Dong Ket 11
Helsinki 11
Johannesburg 11
Paris 11
Stockholm 11
Chennai 10
Falls Church 10
Poplar 10
Charlotte 9
Denver 9
San Paolo di Civitate 9
Baghdad 8
Menlo Park 8
Mexico City 8
Porto Alegre 8
Redwood City 8
Rio de Janeiro 8
San Francisco 8
Terni 8
Vienna 8
Dhaka 7
Guangzhou 7
Haiphong 7
Hefei 7
London 7
Queens 7
Tashkent 7
Ankara 6
Belo Horizonte 6
Columbus 6
Curitiba 6
Goiânia 6
Istanbul 6
Kuala Lumpur 6
Lausanne 6
Lima 6
Prato 6
Riverbank 6
San José 6
Amman 5
Baku 5
Bogotá 5
Bologna 5
Brussels 5
Da Nang 5
Totale 5.012
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 175
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 146
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 128
Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients 123
Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer 116
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 109
Stereotactic radiotherapy for brain metastases: Imaging tools and dosimetric predictive factors for radionecrosis 109
Breakdown of symbiosis in radiation-induced oral mucositis 109
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 108
Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction 105
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 105
Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial 104
Acute and late toxicity after three-dimensional conformal image-guided radiotherapy for localized prostate cancer 104
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer 104
Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications 103
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer 103
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience 103
Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes 101
Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy 100
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 100
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 100
Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. 100
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective 96
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 96
Current therapeutic options in metastatic castration-resistant prostate cancer 94
Prostate Cancer Recurrence in Kidney Transplant Recipient 15 Years After Radical Prostatectomy: A Case Report. 94
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 93
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 92
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 92
Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis 91
Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions 89
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 88
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 87
Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study 84
Stereotactic radiotherapy for liver oligometastases 84
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus 82
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 82
Evaluation of serrated intraprostatic gold coils positional stability using on-board cone beam computed tomography scans acquired throughout the radiation treatment course 82
Predicting genitourinary toxicity in three-dimensional conformal radiotherapy for localized prostate cancer: A dose-volume parameters analysis of the bladder 82
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 82
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 81
Stereotactic radiotherapy for brain oligometastases 81
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study 80
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 80
Choline PET/CT in recurrent prostate cancer 80
Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis 80
Guidelines on prostate carcinoma - AIRO, 2016 79
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 78
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 78
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 78
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 77
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 76
Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases 76
Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases 76
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 76
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 73
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 72
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope? 72
Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: Three longitudinal case studies 72
High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool? 72
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 72
Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer 71
Acute and late toxicities after moderate hypo-fractionated radiation therapy to the chest wall/breast and regional lymph nodes: a retrospective observational study 70
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities 70
Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis 69
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review 69
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer 68
Stereotactic radiotherapy for lung oligometastases 68
Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients 67
Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer 67
Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience 66
Re: PSMA-Guided Metastases Directed Therapy for Bone Castration Sensitive Oligometastatic Prostate Cancer: A Multi-Institutional Study 65
Image-guided-radiotherapy retreatment of spine metastasis: A case report and radiobiological evaluation 65
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 65
The role of adjuvant radiother apy in the treatment of papillary tumors of the pineal region: Some general considerations and a case report 64
Volumetric image-guided conformal radiotherapy for localized prostate cancer: Analysis of dosimetric and clinical factors affecting acute and late toxicity 64
Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach: SBRT in oligometastatic elderly patients 64
Oligometastatic prostate cancer: The game is afoot 64
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 63
Intra-parotid facial nerve schwannoma with intra-temporal extension; A case report. Is there a role for stereotactic radiotherapy? 63
High-dose-rate brachytherapy with surface applicator in penile cancer 63
The time factor in oncology: Consequences on tumour volume and therapeutic planning 62
Stereotactic radiotherapy for bone oligometastases 62
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives 62
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 61
The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation 60
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 59
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis 58
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 55
Radiotherapy in the era of COVID-19 55
Retro-orbital granulocytic sarcoma: Case report 53
Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator (TM) micro-MLC: A dosimetric analysis 53
Stereotactic radiotherapy for oligometastases in the lymph nodes 53
The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer 52
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature 52
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 50
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 47
Editorial: Reviews in genitourinary oncology 41
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 28
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 27
Totale 7.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 0 0 0 6 4 5 2 152 11 33 48 150
2022/20231.118 77 264 14 50 64 97 10 60 432 3 40 7
2023/2024519 25 48 24 15 6 0 141 6 34 14 97 109
2024/20251.490 23 120 45 40 229 62 45 106 380 94 244 102
2025/20263.134 224 220 170 326 428 301 629 214 271 228 82 41
2026/2027914 64 118 184 548 0 0 0 0 0 0 0 0
Totale 7.969